TrialReach nabs $13.5 mln Series B
Clinical trial information provider TrialReach has secured $13.5 million in Series B funding. Smedvig Capital led the round with participation from return backers Amadeus Capital Partners and Octopus Investments.
5 February 2015•3 mins read
